AAAAAA

   
Results: 1-7 |
Results: 7

Authors: MOODLEY J MOODLEY D PILLAY K COOVADIA H SABA J VANLEEUWEN R GOODWIN C HARRIGAN PR MOORE KHP STONE C PLUMB R JOHNSON MA
Citation: J. Moodley et al., PHARMACOKINETICS AND ANTIRETROVIRAL ACTIVITY OF LAMIVUDINE ALONE OR WHEN COADMINISTERED WITH ZIDOVUDINE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PREGNANT-WOMEN AND THEIR OFFSPRING, The Journal of infectious diseases, 178(5), 1998, pp. 1327-1333

Authors: MOORE KHP HUSSEY EK SHAW S FUSEAU E DUQUESNOY C PAKES GE
Citation: Khp. Moore et al., SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUMATRIPTAN IN HEALTHY-SUBJECTS FOLLOWING ASCENDING SINGLE INTRANASAL DOSES AND MULTIPLE INTRANASAL DOSES, Cephalalgia, 17(4), 1997, pp. 541-550

Authors: MINTO CF SCHNIDER TW EGAN TD YOUNGS E LEMMENS HJM GAMBUS PL BILLARD V HOKE JF MOORE KHP HERMANN DJ MUIR KT MANDEMA JW SHAFER SL
Citation: Cf. Minto et al., INFLUENCE OF AGE AND GENDER ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL .1. MODEL DEVELOPMENT, Anesthesiology, 86(1), 1997, pp. 10-23

Authors: MOORE KHP BROUWER KLR JOYNER PU
Citation: Khp. Moore et al., LESSONS GAINED FROM DISTANCE DELIVERY OF AN APPLIED PHARMACOKINETICS COURSE, American journal of pharmaceutical education, 61(3), 1997, pp. 310-313

Authors: MOORE KHP YUEN GJ RAASCH RH ERON JJ MARTIN D MYDLOW PK HUSSEY EK
Citation: Khp. Moore et al., PHARMACOKINETICS OF LAMIVUDINE ADMINISTERED ALONE AND WITH TRIMETHOPRIMSULFAMETHOXAZOLE, Clinical pharmacology and therapeutics, 59(5), 1996, pp. 550-558

Authors: MOORE KHP BROUWER KLR
Citation: Khp. Moore et Klr. Brouwer, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC EVALUATION OF THE EFFECT OF HEAT-TREATMENT ON TRIMETHOPRIM AND SULFAMETHOXAZOLE STABILITY IN SERUM, Therapeutic drug monitoring, 17(4), 1995, pp. 356-360

Authors: MOORE KHP RAASCH RH BROUWER KLR OPHEIM K CHEESEMAN SH EYSTER E LEMON SM VANDERHORST CM
Citation: Khp. Moore et al., PHARMACOKINETICS AND BIOAVAILABILITY OF ZIDOVUDINE AND ITS GLUCURONIDATED METABOLITE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND HEPATIC-DISEASE (AIDS CLINICAL-TRIALS GROUP PROTOCOL-062), Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2732-2737
Risultati: 1-7 |